Digital value-added medicines - a key driver for 2020
Pharmapack also identifies waste management and the use of blockchain as key trends for the year ahead.
Pharmapack Europe has pinpointed a number of opportunities and threats that drug delivery and pharmaceutical packaging companies must address in 2020. The event, widely seen as Europe’s leading hub for the pharmaceutical packaging and drug delivery industry, will take place next week at the Porte De Versailles in Paris with executives meeting to debate key trends, learn new insights and meet new partners.
This year’s conference agenda provides a window into the biggest developments likely to impact the industry in the year ahead. Trends at this year’s Pharmapack include digital value-added medicines, increased need for waste management, formulation triggering device development in biologics and the use of blockchain.
One key session generating significant interest amongst delegates is the connectivity and patient centricity session. Aurelio Arias, Senior Consultant, European Thought Leadership at IQVIA, will discuss the role devices have on value-added medicines (VAM) and how patient centricity and good product design are transforming the perception of medical devices – which are now integral to many patient therapies.
In a year when the industry has begun exploring the full life cycle impact of medicines, the agenda will explore everything from a collaborative value chain approach to enabling plastic recycling. These themes, as well as a talk around recovering and managing waste generated by used medicines, will be discussed in a sustainability panel chaired by Gregor Anderson, Managing Director at Pharmacentric Solutions.
In the biologics space, Pharmapack speakers will discuss the global outlook of biologics and biosimilars as well as the complexities of delivering a biologic drug to market. Biologics are having a significant impact on device development. Christian Dechant, Director of Primary Packaging Development Biologicals, Pharmaceutical Development Biologicals at Boehringer Ingelheim, will discuss how formulation is triggering device development within the space.
The event will also explore the challenge in bridging the development gap between clinical and commercial applications as the number of innovators increases within the market. Harmonising the creative work of small players and the complexity of large, highly regulated markets and increasingly complicated therapeutic systems will be a major challenge in the industry in 2020.
In a final trend emerging from Pharmapack, the use of blockchain technology in the pharma supply chain is expected to increase throughout the course of 2020. Jason Lacombe, CEO at Veratrak will discuss how blockchain is currently being used by contract packaging organisations in the pharma supply chain and its growth potential.
Another highlight are the in-depth Workshops – a series of 45-minute technical presentations – featuring interactive case-studies on new approaches, and how to overcome challenges and technical problems in product development, as well as sessions on Indian and Chinese pharma. The speakers feature a who’s who of leading international companies including Becton Dickinson, Sonceboz, Sensile Medical, Gerresheimer, Schreiner MediPharm, LOG, SGD Pharma, Bormioli Pharma, and Covestro.
Paving the way for new innovations to the market, the Pharmapack Awards and Start-up Hub are both growing in importance as more diverse companies bring patient-changing innovations to market. All exhibitor innovations submitted for the Pharmapack Awards are showcased in the Innovation Gallery, which gives a comprehensive overview of recently launched products as well as hour-long guided Innovation Tours delivered by industry experts.
“It is an extremely exciting time for the pharmaceutical packaging and drug delivery industry, as in recent years more innovative products are being brought to market. With the industry harbouring goals of going greener, managing waste generated by used medicines will be vital in bringing these goals into fruition. Pharmapack Europe’s content-rich agenda, coupled with the unique business platform it provides for executives to nurture existing relationships and establish new ones, have played a significant role in helping proliferate new innovations to market,” says Silvia Forroova, Brand Director at Pharmapack Europe.
News CPHI Frankfurt: Interview with Marcelo Cruz, Vice President, Business Development & Marketing at TjoapackIn this series of interviews, we caught up with some of the exhibitors at CPHI Frankfurt to discover what innovations are being brought to the pharmaceutical industry this year. Here we chat with Marcelo Cruz of Tjoapack to discuss how global events ar...
News CPHI Frankfurt 2022: Innovator Interviews – BioibericaIn this series of interviews, we speak to the companies on the CPHI Frankfurt show floor who are driving innovation in pharma for a better healthcare future. We caught up with Mónica Gómez Navarro (Marketing Manager Branded Ingredients), ...
News CPHI Frankfurt 2022: Innovator Interview – Procaps GroupIn this series of interviews, we speak to the companies on the CPHI Frankfurt show floor who are driving innovation in pharma for a better healthcare future. We interviewed Rosella Del Vecchio Herrera, Marketing Director at Procaps Group, to discover h...
News From the floor - CPHI Frankfurt 2022The live blog from the people on the ground at CPHI Frankfurt - covering all stand-out news, memorable moments, and keynote updates from the 2022 event.
News How to Commercialise an Advanced Therapy: Connect to Frankfurt on-demandIn this Connect to Frankfurt session, Andrea Zobel, Senior Director, Personalized Supply Chain at World Courier (Berlin Germany), Melissa Lattanzi, VP Emerging Therapies at AmerisourceBergen (King of Prussia, USA), and Hans-Peter Scherzer, Customer Suc...
News CDMO - Health is a Joint Project: Connect to Frankfurt on-demandIn this Connect to Frankfurt session, Emanuele Agnese, Business Development Manager and Pietro Allegrini, R&D Director at Indena, present the ways in which a reliable manufacturing partner in the pursuit of better health outcomes for patients and pharm...
News Streamlined Development for Efficient Production of Bispecific Molecules: Connect to Frankfurt on-demandIn this Connect to Frankfurt session, Séverine Fagète, VP, Cell Line Development Services at Selexis (Geneva, Switzerland), and Brandon Brino (Durham, USA), Process Development Scientist and Group Leader at KBI Biopharma, present an overv...
News MDR – How to collect post-market clinical follow-up data (PMCF): Connect to Frankfurt on-demandIn this Connect to Frankfurt session, Philipp Annecke, Junior Key Account Manager and Heinrich Martens, VP Regulatory Affairs of Fresenius Kabi (Bad Homburg, Germany) present guidances from the Medical Devices Regulation on clinical data evaluatio...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
Generate high-quality, engaged leads for your business, all year round
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
Your company’s profile boosted at all participating CPHI events
An easy-to-use platform with a detailed dashboard showing your leads and performance